ATE466958T1 - Klassifizierung von kolonkrebs - Google Patents

Klassifizierung von kolonkrebs

Info

Publication number
ATE466958T1
ATE466958T1 AT04803064T AT04803064T ATE466958T1 AT E466958 T1 ATE466958 T1 AT E466958T1 AT 04803064 T AT04803064 T AT 04803064T AT 04803064 T AT04803064 T AT 04803064T AT E466958 T1 ATE466958 T1 AT E466958T1
Authority
AT
Austria
Prior art keywords
cancer
classification
colon cancer
treatment
relates
Prior art date
Application number
AT04803064T
Other languages
English (en)
Inventor
Torben Yrntoft
Jens Jensen
Mogens Kruhyffer
Paeivi Laiho
Lauri Aaltonen
Original Assignee
Aros Applied Biotechnology As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aros Applied Biotechnology As filed Critical Aros Applied Biotechnology As
Application granted granted Critical
Publication of ATE466958T1 publication Critical patent/ATE466958T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04803064T 2003-12-27 2004-12-23 Klassifizierung von kolonkrebs ATE466958T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA200301940 2003-12-27
DKPA200400096 2004-01-24
DKPA200400586 2004-04-07
DKPA200401843 2004-11-26
PCT/DK2004/000914 WO2005064009A1 (en) 2003-12-27 2004-12-23 Classification of cancer

Publications (1)

Publication Number Publication Date
ATE466958T1 true ATE466958T1 (de) 2010-05-15

Family

ID=34743750

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04803064T ATE466958T1 (de) 2003-12-27 2004-12-23 Klassifizierung von kolonkrebs

Country Status (6)

Country Link
US (1) US20090297506A1 (de)
EP (1) EP1704248B1 (de)
AT (1) ATE466958T1 (de)
CA (1) CA2592504A1 (de)
DE (1) DE602004027086D1 (de)
WO (1) WO2005064009A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1672079A1 (de) * 2004-12-20 2006-06-21 Georg-August-Universität Göttingen Stiftung öffentlichen Rechts Verfahren für Krebsdiagnose
NZ544432A (en) 2005-12-23 2009-07-31 Pacific Edge Biotechnology Ltd Prognosis prediction for colorectal cancer using a prognositc signature comprising markers ME2 and FAS
WO2008141480A1 (en) * 2007-05-22 2008-11-27 Human Antibodomics (Shanghai) Inc. Human angiostatin interacting and tumor metastasis involving protein variants and uses thereof
EP2218794A1 (de) * 2009-02-13 2010-08-18 Alphagenics International SA Instabilitätserkennung in Regionen mit genomischem DNA mit einfacher Tandemwiederholung
WO2012087144A2 (en) * 2010-12-23 2012-06-28 Agendia N.V. Methods and means for molecular classification of colorectal cancers
WO2013113696A1 (en) 2012-01-30 2013-08-08 Vib Vzw Means and method for diagnosis and treatment of alzheimer's disease
EP2700949A1 (de) 2012-08-24 2014-02-26 IMG Institut für medizinische Genomforschung Planungsgesellschaft M.B.H. Verwendung von Biliverdinreduktaseproteinen als Krebsmarker
KR20230030022A (ko) 2014-11-13 2023-03-03 더 존스 홉킨스 유니버시티 관문 차단 및 미소부수체 불안정성

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1361286A1 (de) * 2002-04-18 2003-11-12 MTM Laboratories AG Methode, um Krebs zu detektieren

Also Published As

Publication number Publication date
WO2005064009A1 (en) 2005-07-14
EP1704248B1 (de) 2010-05-05
EP1704248A1 (de) 2006-09-27
WO2005064009A9 (en) 2009-11-05
DE602004027086D1 (de) 2010-06-17
US20090297506A1 (en) 2009-12-03
CA2592504A1 (en) 2005-07-14

Similar Documents

Publication Publication Date Title
ATE470723T1 (de) Genexpressionsmarker für die prognose von brustkrebs
BRPI0411743A (pt) método e composições para tratar doenças relacionadas a amilóides
ATE445386T1 (de) Polymerische parfümpartikel
BRPI0513029A (pt) método para produzir uma proteìna de eritropoietina carbamilada, proteìna de eritropoietina carbamilada, composto, composição farmacêutica, métodos de tratamento de uma doença ou condição crÈnica, sub-crÈnica e aguda e de tratamento de uma doença do sistema nervoso central ou sistema nervoso periférico, e, uso de um composto
TW200600087A (en) Methods and compositions for treating amyloid-related diseases
HUP0402239A2 (hu) Eltérően oxialkilezett poliolok keverékén alapuló, sugárzásra keményedő uretán-akrilátok
DE60329274D1 (de) Kontrastmittel und verfahren zum imaging von naaldase oder psma
WO2004066941A3 (en) Expression profiles for colon cancer and methods of use
EP1990059A3 (de) Verfahren zur Behandlung von Krebs
WO2007009755A8 (en) Compositions and methods for cancer diagnostics comprising pan-cancer markers
MY142988A (en) Novel aminobenzophenone compounds
DE60332096D1 (de) Mikrosatellitenmarker in form von mononukleotidwiederholungen zur detektion von mikrosatelliteninstabilität
NO20055741L (no) Nye kjemiske forbindelser
DE60109430D1 (de) An entzündlichen darmerkrankungen beteiligte gene und deren verwendung
DE602004031458D1 (de) Verfahren zur erhöhung der refinerproduktionsrate und/oder verringerung der spezifischen energie des aufschliessens von holz
ATE466958T1 (de) Klassifizierung von kolonkrebs
WO2004029283A3 (en) Subtelomeric dna probes and method of producing the same
ATE443135T1 (de) Fluoreszenzprotein und pigmentprotein
ECSP056057A (es) Compuestos de benzo[1,2,5]tiadiazole
BRPI0415355A (pt) triarilimidazóis
BRPI0408238A (pt) anticorpo, método de detectar cáncer, conjunto para detecção de cáncer, e, composição farmacêutica para tratar cáncer
DK1633861T3 (da) Krystallinsk VAP-1 og anvendelser deraf
WO2003030719A3 (en) Methods and kits for use in selecting approaches to treating cancer
ATE442382T1 (de) Ein die mam-domäne enthaltendes protein
ATE437846T1 (de) Cyclooct-(en-)yl-derivate zur verwendung als duftstoffe

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties